Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianting Sheng

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
IEEE Journal of Biomedical and Health Informatics|March 18, 2015
Optimal drug prediction from personal genomics profilesJianting Sheng, Fuhai Li, Stephen T C Wong
Trends in Immunology|October 23, 2024
Systems immunology insights into brain metastasisWenjuan Dong, Jianting Sheng, Johnny Z M Cui, et al.
Bioinformatics (Oxford, England)|June 17, 2014
DrugComboRanker: drug combination discovery based on target network analysisLei Huang, Fuhai Li, Jianting Sheng, et al.
Patterns (New York, N.Y.)|May 27, 2024
MUSTANG: Multi-sample spatial transcriptomics data analysis with cross-sample transcriptional similarity guidanceSeyednami Niyakan, Jianting Sheng, Yuliang Cao, et al.
Oncotarget|August 31, 2015
Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers depositionXiaoping Zhu, Jing Zhong, Zhen Zhao, et al.
Cancer Research|September 17, 2025
Spatial Cross-talk Modeling of the Tumor Microenvironment Identifies CCR5-Mediated Glia-to-Glia Signaling as a Key Regulator of Brain Metastatic ProgressionJu Young Ahn, Wenjuan Dong, Akshjot Puri, et al.
Elife|September 11, 2024
Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast CancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Cancer Research|February 14, 2023
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer SurvivorsSammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, et al.
Cancer Letters|November 2, 2019
Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathwaysXiang Nan, Jiang Wang, Hao Cheng, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
IEEE Journal of Biomedical and Health Informatics|March 18, 2015
Optimal drug prediction from personal genomics profilesJianting Sheng, Fuhai Li, Stephen T C Wong
Trends in Immunology|October 23, 2024
Systems immunology insights into brain metastasisWenjuan Dong, Jianting Sheng, Johnny Z M Cui, et al.
Bioinformatics (Oxford, England)|June 17, 2014
DrugComboRanker: drug combination discovery based on target network analysisLei Huang, Fuhai Li, Jianting Sheng, et al.
Patterns (New York, N.Y.)|May 27, 2024
MUSTANG: Multi-sample spatial transcriptomics data analysis with cross-sample transcriptional similarity guidanceSeyednami Niyakan, Jianting Sheng, Yuliang Cao, et al.
Oncotarget|August 31, 2015
Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers depositionXiaoping Zhu, Jing Zhong, Zhen Zhao, et al.
Cancer Research|September 17, 2025
Spatial Cross-talk Modeling of the Tumor Microenvironment Identifies CCR5-Mediated Glia-to-Glia Signaling as a Key Regulator of Brain Metastatic ProgressionJu Young Ahn, Wenjuan Dong, Akshjot Puri, et al.
Elife|September 11, 2024
Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast CancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Cancer Research|February 14, 2023
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer SurvivorsSammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, et al.
Cancer Letters|November 2, 2019
Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathwaysXiang Nan, Jiang Wang, Hao Cheng, et al.
Pageof 3